高半胱天冬酶3表达与双重BCL2家族抑制对ETO2::GLIS2儿童白血病的易感性
本研究通过诱导型ETO2::GLIS2细胞模型发现,ETO2::GLIS2表达可上调CASP3转录、激活半胱天冬酶3并导致细胞死亡;患者来源的ETO2::GLIS2阳性白血病细胞同时高表达CASP3和BCL2,BH3谱分析显示BCL2抑制使细胞对MCL1抑制敏感,提示BCL2与MCL1功能冗余,体内患者来源异种移植模型证实联合抑制BCL2和MCL1才能阻断疾病进展。
要点
- ETO2::GLIS2表达上调CASP3转录并激活半胱天冬酶3,诱导细胞死亡。
- 患者ETO2::GLIS2阳性白血病细胞高表达CASP3和BCL2。
- 联合抑制BCL2和MCL1在体内模型中阻断疾病进展。
核心结论
- ETO2::GLIS2表达的转录后果包括正向调控促凋亡的CASP3,并与对两个BCL2家族成员联合靶向的易感性相关,为该侵袭性儿童AML亚组提供了新的治疗视角。
研究设计与样本
- 研究采用诱导型ETO2::GLIS2细胞模型、患者来源的白血病细胞以及体内患者来源异种移植模型。
主要发现
- 在人细胞中诱导ETO2::GLIS2表达导致CASP3转录增加、CASP3激活和细胞死亡。
- 患者来源的ETO2::GLIS2阳性白血病细胞同时高表达CASP3和高表达BCL2。
- BCL2抑制部分抑制ETO2::GLIS2阳性白血病细胞增殖,BH3谱分析显示BCL2抑制使这些细胞对MCL1抑制敏感,提示BCL2与MCL1之间存在功能冗余。
- 在体内患者来源异种移植模型中,联合抑制BCL2和MCL1是阻断疾病进展所必需的。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pediatric acute myeloid leukemia expressing the ETO2::GLIS2 fusion oncogene is associated with dismal prognosis. Previous studies have shown that ETO2::GLIS2 can efficiently induce leukemia development associated with strong transcriptional changes but those amenable to pharmacological targeting remained to be identified. By studying an inducible ETO2::GLIS2 cellular model, we uncovered that de novo ETO2::GLIS2 expression in human cells led to increased CASP3 transcription, CASP3 activation, and cell death. Patient-derived ETO2::GLIS2+ leukemic cells expressed both high CASP3 and high BCL2. While BCL2 inhibition partly inhibited ETO2::GLIS2+ leukemic cell proliferation, BH3 profiling revealed that it also sensitized these cells to MCL1 inhibition indicating a functional redundancy between BCL2 and MCL1. We further show that combined inhibition of BCL2 and MCL1 is mandatory to abrogate disease progression using in vivo patient-derived xenograft models. These data reveal that a transcriptional consequence of ETO2::GLIS2 expression includes a positive regulation of the pro-apoptotic CASP3 and associates with a vulnerability to combined targeting of two BCL2 family members providing a novel therapeutic perspective for this aggressive pediatric AML subgroup.
引用
- Aid Z, Robert E, Lopez CK, et al. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia. Leukemia. 2022. PMID: 36585521. doi:10.1038/s41375-022-01800-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。